Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Takeda slams brakes on narcolepsy program, stopping 2 studies early in response to safety signal,

Japan-based Takeda saw the safety signal in phase 2 clinical trials of TAK-994, an oral orexin agonist that is designed to increase wakefulness. Takeda moved …, Japan-based Takeda saw the safety signal in phase 2 clinical trials of TAK-994, an oral orexin agonist that is designed to increase wakefulness. Takeda moved …, Read More

Scroll to Top